XML 46 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Schedule II

CROSS COUNTRY HEALTHCARE, INC.
VALUATION AND QUALIFYING ACCOUNTS
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023, AND 2022
 
Balance at
Beginning
of Period
Charged to (Released from) Operations Write-Offs, Net of RecoveriesOther
Changes
 Balance at
End
of Period
(amounts in thousands)
Allowances for Accounts Receivable
Year Ended December 31, 2024$20,547 $22,077  $(33,323)(a)$— $9,301 
Year Ended December 31, 2023$14,696 $17,355  $(11,504)(a)$— $20,547 
Year Ended December 31, 2022$6,881 $15,327  $(7,512)(a)$— $14,696 
Valuation Allowance for Deferred Tax Assets       
Year Ended December 31, 2024$$176 $— $— $178 
Year Ended December 31, 2023$$— $— $— $
Year Ended December 31, 2022$20 $— $(18)$— $
________________

(a) Uncollectible accounts written off, net of recoveries.